Support Vector Machine |
diagnostic classification, intratumoral heterogeneity; tissue-selective genes; gene prediction; gene selection; disease-gene association; gene expression analysis; signatures from gene-pathway; disease gene prioritization; miRNA signatures |
157 |
Random Forest |
diagnostic classification, tissue-selective genes; gene prediction; co-acting gene networks; gene selection; mutation-gene-drug relations; gene expression analysis; miRNA biomarkers; drug-induced gene expression; sample-classification |
124 |
Logistic Regression |
gene prediction; gene selection; drug-induced gene expression |
38 |
Deep Neural Network |
mutation-gene-drug relations; gene expression analysis |
36 |
LASSO |
intratumoral heterogeneity; biomarkers selection; gene selection; gene expression analysis |
31 |
Naive Bayes |
gene selection; pharmacogenetic prediction |
28 |
K-Nearest Neighbor |
gene selection |
28 |
Artificial Neural Network |
gene selection; genotype-phenotype analysis; risk classification; transcriptome profiling; variant extraction |
25 |
Autoencoder |
gene prediction |
24 |
Principal Component Analysis |
single-cell analysis; gene expression |
19 |
Linear Discriminant Analysis |
transcriptome profiling; miRNA biomarkers; taxa-condition association |
14 |
Perceptron |
gene selection; gene prediction |
12 |
K-means |
candidate miRNA targets |
8 |